Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study-Reference-Cited by-同舟云学术

Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study

Published:2014-07 Issue:7 Volume:13 Page:657-665
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Calabresi Peter A,Kieseier Bernd C,Arnold Douglas L,Balcer Laura J,Boyko Alexey,Pelletier Jean,Liu Shifang,Zhu Ying,Seddighzadeh Ali,Hung Serena,Deykin Aaron

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference29 articles.

1. A meta-analysis of the efficacy and tolerability of interferon-beta in multiple sclerosis, overall and by drug and disease type;Nikfar;Clin Ther,2010

2. PEGylation: an approach for drug delivery. A review;Jain;Crit Rev Ther Drug Carrier Syst,2008

3. Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis;Menzin;J Manag Care Pharm,2013

4. Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence;Patti;Patient Prefer Adher,2010

5. The prevalence of injection-site reactions with disease-modifying therapies and their effect on adherence in patients with multiple sclerosis: an observational study;Beer;BMC Neurol,2011

Cited by 342 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7;Cell Calcium;2024-11

2. Efficacy and safety of peginterferon beta-1a compared to interferon beta-1a in relapsing remitting multiple sclerosis patients: A phase 3, randomized, non-inferiority clinical trial (PEGINTEGRITY);Multiple Sclerosis and Related Disorders;2024-10

3. Privacy-by-design generation of two virtual clinical trials in multiple sclerosis and their release as open datasets;2024-09-02

4. The molecular dynamics simulation of coronavirus- based compound (6OHW structure) interaction with interferon beta-1a protein at different temperatures and pressures: Virus destruction process;International Communications in Heat and Mass Transfer;2024-09

5. Sampeginterferon beta-1a in clinical practice;Neurology, Neuropsychiatry, Psychosomatics;2024-08-07